STOCK TITAN

Zhibao Tech Stock Price, News & Analysis

ZBAO Nasdaq

Welcome to our dedicated page for Zhibao Tech news (Ticker: ZBAO), a resource for investors and traders seeking the latest updates and insights on Zhibao Tech stock.

Zhibao Technology Inc. (NASDAQ: ZBAO) is an InsurTech company whose operating entities in China focus on digital insurance brokerage services built around a 2B2C digital embedded insurance model. The ZBAO news feed on Stock Titan aggregates company announcements, operational updates, financing developments and regulatory disclosures that Zhibao releases through press wires and SEC filings.

News about Zhibao often highlights the performance and expansion of its digital brokerage platform, including growth in B channels and C-end customers served through its embedded insurance model. The company’s communications also cover the development of its over 40 proprietary digital insurance solutions across industries such as travel, sports, logistics, utilities and e-commerce, as well as its use of big data and AI to iterate and enhance these solutions.

Investors following ZBAO can expect updates on health and medical insurance initiatives, including products launched through its subsidiary Zhibao Health and collaborations with partners like the People’s Insurance Company of China (PICC). News items also describe joint ventures such as Zhibao Yingshi and Zhongfang JV, which relate to medical insurance and risk reduction services, along with the integration of Zhibao’s Managing General Underwriter (MGU) capabilities into these structures.

Another recurring news theme is Zhibao’s reinsurance activities through Zhibao Labuan Reinsurance Company Limited, including licensing milestones and credit ratings from AM Best. Coverage may also include capital markets developments such as equity purchase agreements, consulting arrangements tied to financing, and participation in investor conferences and webinars.

Regulatory and listing updates, including Nasdaq deficiency notices related to periodic filings and changes in independent auditors, are also part of the ZBAO news flow. By reviewing this news page, readers can track how Zhibao communicates its financial performance, strategic partnerships, product launches and governance developments over time.

Rhea-AI Summary

Zhibao Technology (NASDAQ: ZBAO) announced it regained compliance with Nasdaq Listing Rule 5250(c)(1) after filing its Form 20-F for the fiscal year ended June 30, 2025 on January 9, 2026. Nasdaq issued a Compliance Notice on January 12, 2026 confirming the company timely filed periodic reports with the SEC and is no longer out of compliance. Zhibao had previously been notified of noncompliance on November 19, 2025 due to the delayed 2025 Annual Report. The filing restored the company’s standing with Nasdaq and closed the compliance matter.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.46%
Tags
none
-
Rhea-AI Summary

Zhibao Technology (NASDAQ: ZBAO) reported fiscal year 2025 results for the 12 months ended June 30, 2025. Revenues rose 51% to RMB 276.9 million (US$38.7M), driven by digital insurance brokerage growth. Gross profit was RMB 113.6 million (gross margin 41.0%). GWP increased from RMB 1.19 billion to RMB 1.57 billion. The company recorded a net loss of RMB 62.0 million (US$8.7M)loss from operations RMB 53.5 million. Cash and equivalents rose to RMB 10.3 million from RMB 2.4 million. Key corporate moves included a 51% acquisition of Zhonglian for RMB 25.5 million (to be paid in installments), formation plans for Zhongfang JV, and Zhibao Labuan receiving a general reinsurance license and AM Best ratings during 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.63%
Tags
-
Rhea-AI Summary

Zhibao Technology (NASDAQ: ZBAO) announced the launch and commencement of operations of Shanghai Zhibao Yingshi Health Technology, a joint venture formed in September 2025 with Shanghai Xingtao Network Technology (Yingshi Health).

Zhibao China holds 51% of the JV, contributed capital, and will merge its MGU team and business into the JV. The JV recorded its first revenue in November 2025, mainly from service fees on mid/high-end medical policies issued by Pingan P&C branches. Preliminary targets: RMB 4 million monthly for the remainder of 2025 and RMB 50 million revenue for 2026, with an annual growth floor of not less than 10%, subject to board confirmation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.93%
Tags
partnership
Rhea-AI Summary

Zhibao Technology (NASDAQ: ZBAO) announced three executive appointments effective December 1, 2025: Xiaowei Le as Chief Operating Officer, Xiao Luo as Chief Marketing Officer, and Guangtong Ren as Chief Actuary. All three were promoted from Zhibao's China operating entities and are cited as contributors to recent performance.

Key facts: Mr. Le is credited with driving over 70% year‑over‑year revenue growth for Zhibao China while serving as Chief Growth Officer; Mr. Luo is a co‑founder focused on B channel expansion and partner outreach; Mr. Ren will lead product pricing and serve as Principal Officer of Zhibao Labuan Re.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.95%
Tags
management
-
Rhea-AI Summary

Zhibao Technology (NASDAQ: ZBAO) received a deficiency letter from Nasdaq for non-compliance with Nasdaq Listing Rule 5250(c)(1) due to its failure to file the Form 20-F for fiscal year ended June 30, 2025. The notice has no immediate effect on the listing of the Company's Class A ordinary shares.

The Company has 60 calendar days to submit a plan to Nasdaq to regain compliance. If Nasdaq accepts a plan, it may grant up to 180 calendar days from the annual report's due date, which would extend the compliance deadline to May 13, 2026. If Nasdaq does not accept a plan, the Company may appeal to a Nasdaq Hearings Panel. The Company intends to file the 2025 Annual Report as soon as practicable and, if necessary, submit a plan to regain compliance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.03%
Tags
none
-
Rhea-AI Summary

Zhibao Technology (NASDAQ: ZBAO) announced it was unable to file its Form 20-F annual report by the November 17, 2025 deadline and cancelled the earnings call scheduled for November 18, 2025 at 10:00 AM ET. The company said it is working to file the Annual Report as soon as possible and will announce a new date and time for the earnings call.

This update confirms a missed filing deadline and a near-term change to investor communications while the company completes its annual report.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.31%
Tags
none
Rhea-AI Summary

Zhibao Technology (NASDAQ: ZBAO) announced that its wholly owned reinsurance subsidiary, Zhibao Labuan, received an AM Best Financial Strength Rating of B+ and a Long-Term Issuer Credit Rating of bbb- with a stable outlook on November 14, 2025.

AM Best assessed Zhibao Labuan's balance sheet strength as strong, cited adequate operating performance, a limited business profile, and appropriate enterprise risk management. Zhibao Labuan was founded in April 2025, received a general reinsurance license in July 2025, and has not commenced operations as of the press date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.91%
Tags
none
-
Rhea-AI Summary

Zhibao Technology (NASDAQ: ZBAO) announced a delay in filing its audited FY2025 financial results for the year ended June 30, 2025 to allow additional time for year-end audit procedures and testing. The company said it does not anticipate accounting principle issues or auditor disagreements and currently expects to file on or before November 14, 2025. Management updated FY2025 guidance, forecasting revenue growth of 60%–80% year-over-year and continued positive growth in operating profit, B channels, and C-end customers versus FY2024.

As a result of the delay, the FY2025 earnings conference call was moved from November 4, 2025 to November 18, 2025 at 10:00 AM ET, and the investor webinar was rescheduled from November 13, 2025 to December 4, 2025 at 12:00 PM ET. Registration and dial-in details were provided.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.54%
Tags
conferences earnings
-
Rhea-AI Summary

Zhibao Technology (NASDAQ: ZBAO) announced a FY2025 earnings call and issued preliminary revenue growth guidance. Management expects 60%–80% revenue growth for the fiscal year ended June 30, 2025 versus the prior year and said it expects continued positive growth in profit, B channels, and C-end customers. The company will report full FY2025 results by October 31, 2025 and hold an earnings call on November 4, 2025 at 10:00 AM ET with virtual dial-in and a Call Me link available starting 09:45 AM ET.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.04%
Tags
Rhea-AI Summary

Zhibao Technology (NASDAQ: ZBAO) announced participation in two investor events through the end of 2025: the LD Micro Main Event XIX in San Diego (October 19-21, 2025) with a company presentation on October 20 at 2:30 PM PT, and the Skyline Signature Series webinar (virtual) on November 13, 2025 at 12:00 PM ET. The company said these events aim to broaden awareness, grow the shareholder base, present recent developments, and hold live Q&A with management. Registration links are provided for the virtual presentation and webinar.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.99%
Tags
conferences

FAQ

What is the current stock price of Zhibao Tech (ZBAO)?

The current stock price of Zhibao Tech (ZBAO) is $1 as of January 30, 2026.

What is the market cap of Zhibao Tech (ZBAO)?

The market cap of Zhibao Tech (ZBAO) is approximately 33.1M.
Zhibao Tech

Nasdaq:ZBAO

ZBAO Rankings

ZBAO Stock Data

33.10M
8.77M
39.09%
0.55%
0.07%
Insurance Brokers
Financial Services
Link
China
Shanghai

ZBAO RSS Feed